THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Hemodynamic Cardiovascular Risk Factors in Chronic Kidney Disease: What are the Effects of Intervention?

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Seminars in dialysis

• Publication date

  2003-03-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1046/j.1525-139X.2003.16029.xPMID 12641877
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiovascular risk factors and diseases after renal transplantation

  2006cited by this paper
• Anaemia management in chronic kidney disease patients: an overview of current clinical practice.

  2002cited by this paper
• Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.

  2002cited by this paper
• Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease.

  2002cited by this paper
• Plasma Norepinephrine Predicts Survival and Incident Cardiovascular Events in Patients With End-Stage Renal Disease

  2002cited by this paper
• Atherosclerotic renal artery stenosis: epidemiology, cardiovascular outcomes, and clinical prediction rules.

  2002cited by this paper
• Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis.

  2002influential reference
• J-Shaped Relationship between Blood Pressure and Mortality in Hypertensive Patients: New Insights from a Meta-Analysis of Individual-Patient Data

  2002cited by this paper
• Role of anaemia in cardiovascular mortality and morbidity in transplant patients.

  2002cited by this paper
• Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis.

  2002cited by this paper
• Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study.

  2002cited by this paper
• Anemia and iron deficiencies among long-term renal transplant recipients.

  2002cited by this paper
• Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey.

  2002cited by this paper
• Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

  2002cited by this paper
• Impact of Aortic Stiffness Attenuation on Survival of Patients in End-Stage Renal Failure

  2001influential reference
• The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study.

  2001cited by this paper
• Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis.

  2001cited by this paper
• Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

  2001cited by this paper
• Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

  2001cited by this paper
• Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients.

  2001cited by this paper
• Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients.

  2001cited by this paper
• Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients.

  2001cited by this paper
• Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study.

  2001cited by this paper
• Left ventricular mass relates to average systolic blood pressure, but not loss of circadian blood pressure in stable hemodialysis patients: an ambulatory 48-hour blood pressure study.

  2001cited by this paper
• Short daily hemodialysis: blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients.

  2001cited by this paper
• Use of erythropoietin before the initiation of dialysis and its impact on mortality.

  2001cited by this paper
• Effect of parathyroid hormone levels on carotid intima-media thickness after renal transplantation.

  2001cited by this paper
• Effect of closure of the arteriovenous fistula on left ventricular dimensions in renal transplant patients.

  2001cited by this paper
• Effect of fluid and sodium removal on mortality in peritoneal dialysis patients.

  2001cited by this paper
• Interdialytic weight gain, compliance with dialysis regimen, and age are independent predictors of blood pressure in hemodialysis patients.

  2000cited by this paper
• Calcification of the aortic valve in the dialyzed patient.

  2000cited by this paper
• Management strategies for posttransplant hypertension.

  2000cited by this paper
• Effects of haemoglobin normalization on quality of life and cardiovascular parameters in end-stage renal failure.

  2000cited by this paper
• Left Ventricular Hypertrophy and Clinical Outcome in CAPD Patients

  2000cited by this paper
• LONG-TERM CHANGES IN LEFT VENTRICULAR HYPERTROPHY AFTER RENAL TRANSPLANTATION

  2000cited by this paper
• Low‐sodium haemodialysis without fluid removal improves blood pressure control in chronic haemodialysis patients

  2000cited by this paper
• Long-term survival in renal transplant recipients with graft function.

  2000cited by this paper
• Comparison of quinapril versus atenolol: effects on blood pressure and cardiac mass after renal transplantation.

  2000cited by this paper
• Predictors of outcome in severe, asymptomatic aortic stenosis.

  2000cited by this paper
• Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy.

  2000cited by this paper
• THE EFFECTS OF NORMAL AS COMPARED WITH LOW HEMATOCRIT VALUES IN PATIENTS WITH CARDIAC DISEASE WHO ARE RECEIVING HEMODIALYSIS AND EPOETIN

  2000cited by this paper
• Early echocardiographic changes and survival following renal transplantation.

  2000cited by this paper
• Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients. Spanish Cooperative Renal Patients Quality of Life Study Group of the Spanish Society of Nephrology.

  2000cited by this paper
• Hematocrit level and associated mortality in hemodialysis patients.

  1999cited by this paper
• Fluid state and blood pressure control in patients treated with long and short haemodialysis.

  1999cited by this paper
• Impact of aortic stiffness on survival in end-stage renal disease.

  1999cited by this paper
• Physical performance and associated electrolyte changes after haemoglobin normalization: a comparative study in haemodialysis patients.

  1999cited by this paper
• Hematocrit levels and hospitalization risks in hemodialysis patients.

  1999cited by this paper
• Normalizing hematocrit in dialysis patients improves brain function.

  1999cited by this paper
• Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin.

  1999cited by this paper
• A preliminary study of the effects of correction of anemia with recombinant human erythropoietin therapy on sleep, sleep disorders, and daytime sleepiness in hemodialysis patients (The SLEEPO study).

  1999cited by this paper
• Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly.

  1999cited by this paper
• Evolutive aortic stenosis in hemodialysis patients: analysis of risk factors.

  1999cited by this paper
• Long-term evolution of cardiomyopathy in dialysis patients.

  1999cited by this paper
• Prediction of left ventricular geometry by clinic, pre-dialysis and 24-h ambulatory BP monitoring in hemodialysis patients: CREED investigators.

  1999cited by this paper
• Influence of hemodialysis on intravascular volume and vasoactive hormones.

  1999cited by this paper
• The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity--the experience of the Lombardy Dialysis Registry.

  1998cited by this paper
• High-output cardiac failure secondary to a brachiocephalic arteriovenous hemodialysis fistula: two cases.

  1998cited by this paper
• Regression of left ventricular hypertrophy in haemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs.

  1998cited by this paper
• Pre- and posthemodialysis measures of serum albumin levels.

  1998cited by this paper
• The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin.

  1998cited by this paper
• Long-term evolution of cardiomyopathy in dialysis patients.

  1998cited by this paper
• Mode of dialysis therapy and mortality in end-stage renal disease.

  1998cited by this paper
• Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism.

  1998cited by this paper
• Dietary salt restriction and reduction of dialysate sodium to control hypertension in maintenance haemodialysis patients.

  1998cited by this paper
• Nocturnal hypoxemia, night-day arterial pressure changes and left ventricular geometry in dialysis patients.

  1998cited by this paper
• Clinical epidemiology of cardiovascular disease in chronic renal disease.

  1998cited by this paper
• Seasonal changes in blood pressure in patients with end-stage renal disease treated with hemodialysis.

  1998cited by this paper
• Echocardiographic evaluation in long-term continuous ambulatory peritoneal dialysis compared with the hemodialysis patients.

  1998cited by this paper
• Gender differences in mediators of left ventricular hypertrophy in dialysis patients.

  1998cited by this paper
• Possible Neurophysiological Markers of Genetic Predisposition to Alzheimer’s Disease

  1998cited by this paper
• Pre- and posthemodialysis measures of serum albumin levels

  1998cited by this paper
• Cardiac disease in chronic uremia: pathogenesis.

  1997cited by this paper
• A critical evaluation of ultrasound measurement of inferior vena cava diameter in assessing dry weight in normotensive and hypertensive hemodialysis patients.

  1997cited by this paper
• Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction.

  1997cited by this paper
• Posttransplant diastolic hypertension: associations with intragraft transforming growth factor-beta, endothelin, and renin transcription.

  1997cited by this paper
• Anemia in hemodialysis patients: variables affecting this outcome predictor.

  1997cited by this paper
• Relationship between left ventricular hypertrophy, myocardial contractility, and load conditions in hemodialysis patients: an echocardiographic study.

  1997cited by this paper
• POSTTRANSPLANT DIASTOLIC HYPERTENSION: Associations with Intragraft Transforming Growth Factor-??, Endothelin, and Renin Transcription1,2

  1997cited by this paper
• Interdialytic weight gain and 48-h blood pressure in haemodialysis patients.

  1997cited by this paper
• Outcome and risk factors for left ventricular disorders in chronic uraemia.

  1996cited by this paper
• Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease.

  1996cited by this paper
• The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease.

  1996cited by this paper
• Results and complications of arteriovenous access dialysis grafts in the lower extremity: a five year review.

  1996cited by this paper
• Arterial blood pressure and left ventricular hypertrophy in haemodialysis patients

  1996cited by this paper
• Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention.

  1996cited by this paper
• Cardiac and arterial interactions in end-stage renal disease.

  1996cited by this paper
• Clinical and echocardiographic disease in patients starting end-stage renal disease therapy.

  1995cited by this paper
• Stretch-induced programmed myocyte cell death.

  1995cited by this paper
• Normalization of hematocrit with recombinant human erythropoietin in chronic hemodialysis patients does not fully improve their exercise tolerance abilities.

  1995cited by this paper
• Hemodynamic consequences of Cimino fistulas studied with finger pressure measurements during fistula compression.

  1995cited by this paper
• Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients.

  1994cited by this paper
• Studies of the vessel wall properties in hemodialysis patients.

  1994cited by this paper
• Acquired aortic stenosis in dialysis patients.

  1994cited by this paper
• A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia.

  1994cited by this paper
• Cardiac Hypertrophy, Aortic Compliance, Peripheral Resistance, and Wave Reflection in End‐Stage Renal Disease: Comparative Effects of ACE Inhibition and Calcium Channel Blockade

  1994cited by this paper
• Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure.

  1994influential reference
• The influence of ACE-inhibition on myocardial mass and diastolic function in chronic hemodialysis patients with adequate control of blood pressure.

  1994cited by this paper
• Wave reflections and cardiac hypertrophy in chronic uremia. Influence of body size.

  1993cited by this paper
• Changes in partition of extracellular fluid volumes in anemic dialyzed uremic patients after partial correction of the anemia with recombinant human erythropoietin treatment.

  1993cited by this paper

• Echocardiographic Assessment of Right Ventricular Function in Normotensive Non Diabetic Hemodialysis Patients

  2017cites this paper
• The Risk Factors for Left Ventricular Hypertrophy in Patients of Stage IV Chronic Kidney Disease

  2016cites this paper
• Autonomic Imaging: The Cardiorenal Axis

  2015cites this paper
• Cardiac sympathetic hyperactivity in chronic kidney disease--a comparison between haemodialysis and peritoneal dialysis patients.

  2014cites this paper
• Hemodialysis and hemodiafiltration differently modulate left ventricular diastolic function

  2013cites this paper
• Relationship of haemodialysis therapy duration and cardiac adrenergic system function assessed by iodine-123 metaiodobenzylguanidine imaging in haemodialysed nondiabetic patients

  2012cites this paper
• Cardiac sympathetic dysfunction in haemodialysed patients.

  2012cites this paper
• Modulation of vitamin D signaling is a potential therapeutic target to lower cardiovascular risk in chronic kidney disease

  2011cites this paper
• [Heart failure in haemodialysis patients: evaluation and treatment].

  2011cites this paper
• Left Ventricular Mass Index Is an Independent Determinant of Diastolic Dysfunction in Patients on Chronic Hemodialysis: A Tissue Doppler Imaging Study

  2010cites this paper
• Arterial Stiffness in Hemodialysis Patients

  2007cites this paper
• Dynamic changes in right ventricular pressures during haemodialysis recorded with an implantable haemodynamic monitor.

  2006cites this paper
• Dialysis Patients and Cardiovascular Problems: Can Technology Help Solve the Complex Equation?

  2005cites this paper
• The cardiovascular burden of the dialysis patient: the impact of dialysis technology.

  2005cites this paper
• Dialysis patients and cardiovascular problems: can technology solve the complex equation?

  2005cites this paper
• Effects of Hemoglobin Normalization with Epoetin in Chronic Kidney Disease

  2005cites this paper
• Improvement of cardiac function after haemodialysis. Quantitative evaluation by colour tissue velocity imaging.

  2004cites this paper
• Hypertension in the Metabolic Syndrome and Diabetes: Pathogenesis, Clinical Studies, and Treatment

  2003cites this paper